Cure: FDA approves tablet form of blood cancer treatment
August 5, 2022
The University of Cincinnati's John Byrd, MD, was featured in a Cure article on the FDA's approval of the tablet form of the drug Calquence to treat multiple blood cancers.
August 5, 2022
The University of Cincinnati's John Byrd, MD, was featured in a Cure article on the FDA's approval of the tablet form of the drug Calquence to treat multiple blood cancers.
August 2, 2022
The University of Cincinnati's Jiajie Diao, PhD, and colleagues have published new research in the journal Nature Communications showing light-activated proteins can help normalize dysfunction within cells.
August 1, 2022
Genetic Engineering & Biotechnology News featured the research of the University of Cincinnati's Agnes (Yu) Luo, PhD, who recently published a journal article showing a drug helped repair nervous system damage in animal models of stroke.
July 28, 2022
Researchers led by the University of Cincinnati's Agnes (Yu) Luo, PhD, have published findings in the journal Cell Reports showing a novel drug helped to repair the damage caused by ischemic stroke in animal models.
July 28, 2022
Siblings Ally and Adam Klaserner are current students in the James L. Winkle College of Pharmacy, and their parents John and Lorrie are alumni of the UC pharmacy program.
July 27, 2022
The University of Cincinnati's Erica Birkley, PhD, was featured by WLWT News to discuss the psychological impact of officer-involved shootings on officers and the treatment methods to clear an officer back to active duty.
July 26, 2022
The University of Cincinnati's Jenni E. Farrow, MD, was featured in a segment on 55KRC's Simply Medicine program to discuss ADHD.
July 25, 2022
The University of Cincinnati's Hyacinth I. Hyacinth was a guest on 55KRC's Simply Medicine program to discuss his research into sickle cell disease, stroke and cognitive impairment.
July 20, 2022
Yahoo News featured the University of Cincinnati's Jennifer Molano in an article about ways to boost your immunity during the BA.5 surge of COVID-19 cases.
July 19, 2022
The University of Cincinnati's Eva Mistry joined 55KRC's Simply Medicine program to discuss the BEST-II clinical trial examining the effects of varying blood pressure targets for patients recovering from a stroke.